Valuation Alpa Laboratories Limited

Stocks

Market Closed - NSE India S.E. 11:05:06 12/11/2026 GMT			5-day change	1st Jan Change
56.71 ^INR	-1.22%		+4.82%	-27.00%

10-12	Alpa Laboratories Limited Approves Appointment of Radhika Biyani as an Independent Director, Effective September 30, 2026	CI
09-17	Alpa Laboratories Limited Announces Appointment of Diksha Jaswani as Company Secretary Cum Compliance Officer, Effective September 17, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	757.5	1,467	1,132	1,752	2,180	977.5
Change	-	93.61%	-22.81%	54.74%	24.44%	-55.15%
Enterprise Value (EV) ¹	334.5	822.3	346.6	875.6	1,053	-376.2
Change	-	145.84%	-57.85%	152.61%	20.26%	-135.73%
P/E	10.5x	10.4x	9x	10.4x	11.2x	6.51x
PBR	0.7x	1.2x	0.84x	1.15x	1.27x	0.52x
PEG	-	0.1x	-0.8x	0.3x	0.7x	-0.3x
Capitalization / Revenue	0.78x	1.19x	1.22x	1.61x	1.94x	0.92x
EV / Revenue	0.34x	0.67x	0.37x	0.81x	0.94x	-0.36x
EV / EBITDA	3.87x	3.83x	4.28x	10.2x	22.4x	-11.4x
EV / EBIT	4.52x	4.16x	5.13x	13.2x	42.1x	-31.4x
EV / FCF	-2.57x	4.89x	5.29x	-15.6x	23.7x	-3.88x
FCF Yield	-38.9%	20.4%	18.9%	-6.4%	4.22%	-25.8%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	3.444	6.697	5.98	7.973	9.269	7.134
Distribution rate	-	-	-	-	-	-
Net sales ¹	975.5	1,230	929.6	1,087	1,125	1,058
EBITDA ¹	86.33	214.4	80.91	86.13	47.03	32.9
EBIT ¹	74.04	197.8	67.62	66.58	25.01	11.98
Net income ¹	72.47	140.9	125.8	167.8	195	150.1
Net Debt ¹	-423	-644.3	-785.4	-876.1	-1,127	-1,354
Reference price ²	36.00	69.70	53.80	83.25	103.60	46.46
Nbr of stocks (in thousands)	21,041	21,041	21,041	21,041	21,041	21,041
Announcement Date	06/09/21	03/09/22	05/09/23	04/09/24	04/09/25	07/09/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ALPA LABORATORIES LIMITED	-	-	-	-	12.88M
ELI LILLY AND COMPANY	42.06x	14.21x	30.18x	0.47%	1,280B
JOHNSON & JOHNSON	41.04x	6.89x	19.37x	1.9%	675B
ABBVIE INC.	37.61x	8.63x	17.8x	2.34%	521B
ROCHE HOLDING AG	21.6x	5.24x	13.13x	2.49%	386B
MERCK & CO., INC.	104.47x	5.96x	25.4x	2.31%	363B
NOVARTIS AG	23.92x	5.8x	14.13x	2.74%	301B
ASTRAZENECA PLC	24.1x	4.84x	13.6x	1.8%	286B
AMGEN INC.	24.17x	7.41x	13.62x	2.16%	253B
GILEAD SCIENCES, INC.	-39.88x	7.38x	46.48x	1.95%	211B
Average	31.01x	7.37x	21.52x	2.02%	428B
Weighted average by Cap.	37.23x	8.91x	22.60x	1.69%